Ischemic Postconditioning in Cardiac Surgery
IPICS
1 other identifier
interventional
209
1 country
1
Brief Summary
Ischemic postconditioning by repetitive cycles of reperfusion and ischemia has been proven both in animal models and in humans. This study aims to investigate the effect of ischemic postconditioning on postoperative hemodynamic function in a standard heart surgery patient population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
March 13, 2013
CompletedFirst Posted
Study publicly available on registry
March 19, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 5, 2018
CompletedDecember 15, 2023
December 1, 2023
5.4 years
March 13, 2013
December 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in cardiac index between the groups during the first postoperative day
Cardiac index is measured by a Swan-Ganz catheter inserted preoperatively
The first postoperative day: measurements at 2, 8 and 18 hrs postoperatively
Study Arms (2)
Ischemic postconditioning
EXPERIMENTALIschemic postconditioning via the cardioplegia line starting with 2 min of reperfusion followed by 2 min of "ischemia" x 3
Control
NO INTERVENTIONStandard operating technique
Interventions
Eligibility Criteria
You may qualify if:
- Patients undergoing elective surgery of the ascending aorta or the aortic valve
You may not qualify if:
- Coronary artery disease requiring bypass surgery
- Tricuspid valve surgery
- Mitral valve surgery
- Atrial fibrillation (permanent or paroxysmal with or without concomitant ablation procedure)
- Patients on per oral or parenteral steroid therapy (inhalational steroids are allowed)
- Patients with autoimmune diseases
- "Redo" operations
- Active endocarditis (ongoing antibiotic therapy)
- On the discretion of the operating surgeon or anaesthesiologist
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Cardiothoracic Surgery, Oslo University Hospital, Ullevål
Oslo, 0424, Norway
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
March 13, 2013
First Posted
March 19, 2013
Study Start
January 1, 2013
Primary Completion
June 1, 2018
Study Completion
June 5, 2018
Last Updated
December 15, 2023
Record last verified: 2023-12